[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US4270923A - Pretreatment agent for subject fluid in pregnancy test - Google Patents

Pretreatment agent for subject fluid in pregnancy test Download PDF

Info

Publication number
US4270923A
US4270923A US06/107,179 US10717979A US4270923A US 4270923 A US4270923 A US 4270923A US 10717979 A US10717979 A US 10717979A US 4270923 A US4270923 A US 4270923A
Authority
US
United States
Prior art keywords
fiber
glass fiber
cation exchange
subject fluid
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US06/107,179
Inventor
Koichi Kondo
Isamu Yoshida
Takashi Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of US4270923A publication Critical patent/US4270923A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Definitions

  • the present invention relates to an improvement in the pretreatment of subject fluids for immunologic pregnancy tests.
  • HCG human chorionic gonadotropin
  • the principle of the anti-HCG antibody-sensitized latex agglutination test is that as a latex particles carrying anti-HCG antibodies as adsorbed thereon are admixed with a subject urine, serum or plasma sample, the latex particles are agglutinated if HCG is present in the sample, the detection of such agglutination establishing a diagnosis of pregnancy.
  • LDAR latex direct agglutination reaction
  • the principle of the HCG-sensitized latex agglutination inhibition test (latex agglutination inhibition reaction; hereinafter briefly, LAIR), is that as a latex carrying HCG as adsorbed thereon is admixed with a given amount of an anti-HCG antiserum, the latex particles are agglutinated, but if the latex is added after admixture of an HCG-containing subject fluid with a given amount of anti-HCG antiserum, the latex will not be agglutinated because the anti-HCG antibody has already been coupled to the HCG in the subject fluid.
  • LAIR the absence of latex agglutination establishes a diagnosis of pregnancy.
  • Another method is the hemagglutination inhibition test (hereinafter briefly, HAIR) in which a diagnosis of pregnancy is performed using HCG-sensitized human or animal red blood cells in place of latex particles.
  • Subject fluids could also be turbid and if such fluids are directly assayed, false results may ensue. To prevent such false results, the fluids are usually filtered prior to the agglutination (inhibition) reaction.
  • the filter materials conventionally employed are cellulosic filter paper, absorbent cotton, cellulose acetate, polyacrylonitrile, carboxylmethylcellulose and other fiber but none of them is fully satisfactory.
  • cellulosic filter paper and absorbent cotton are capable of removing the turbidity but have the disadvantage that HCG is also adsorbed.
  • Cellulose acetate and polyacrylonitrile fiber are not efficient enough to thoroughly remove interferring components.
  • fibrous carboxylmethylcellulose is highly capable of removing the turbidity and interfering components, it entails adsorption of HCG.
  • the present inventors have unexpectedly found that the interfering components and the elements of turbidity present in the subject fluids can be specifically removed without entailing a substantial loss of HCG by contacting the subject fluids with a carboxylic acid-type cation exchange resin fiber or a siliconized glass fiber.
  • the principal object of the present invention is to provide an excellent agent for pretreating a subject fluid for pregnancy tests by means of an immunologic assay of HCG, which consists essentially of a carboxylic acid-type cation exchange resin fiber or a siliconized glass fiber. Another object is to provide an improved method for pretreating the subject fluids with use of said agent.
  • the carboxylic acid-type cation exchange resin fiber used in this invention preferably has a cation exchange capacity of at least about 1.5 meq/g and, especially, about 5 to 8 meq/g.
  • a preferable fiber may be prepared by reacting a polymer molding containing at least 40 weight percent of acrylonitrile with hydrazine or a homolog of hydrazine to provide said polymer molding with an anion exchange capacity of 0.01 to 3.0 meq/g and, then, hydrolyzing the residual nitrile groups with alkali or mineral acid to introduce cation-exchanging groups into the molding (cf. Japanese Patent Application Laid-Open No. 14389/1974 (Tokukai Sho 49-14389)).
  • the siliconized glass fiber may be prepared by treating an ordinary glass fiber with a compound of silicon or a silicon-containing composition such as silane coupling agents (organofunctional silanes), silicone oil, silicone oil emulsion, silicone varnish, silicone varnish emulsion, etc.
  • a compound of silicon or a silicon-containing composition such as silane coupling agents (organofunctional silanes), silicone oil, silicone oil emulsion, silicone varnish, silicone varnish emulsion, etc.
  • This siliconization treatment is generally carried out by impregnating a glass fiber with an aqueous or organic solvent solution of said compound of silicon or silicon-containing composition and heating the fiber (usually at about 100° to 300° C.).
  • the carboxylic acid-type cation exchange resin fiber and siliconized glass fiber may be used alone or in combination.
  • the carboxylic acid-type cation exchange resin fiber is advantageously used in the form of filament or staple fiber (preferably 0.1 to 2 mm in length) with a denier number of about 2 to 15.
  • the siliconized glass fiber is preferably used in the form of filament with a diameter of about 5 to 15 ⁇ m.
  • the fluid In contacting the subject fluid, such as the urine, serum or plasma of a woman, with the above-mentioned fiber, the fluid may be filtered through a layer of the fiber or, alternatively, the fluid may be admixed with the fiber and then separated (by filtration, centrifugal separation, etc.), although it is generally preferable to filter the subject fluid through the fibrous layer.
  • a typical filtration procedure is as follows. A tube (preferably made from polyethylene) is packed with about 20 to 100 mg, most preferably about 50 mg, of said fiber and connected to the lower end of a pipe (preferably made from polyethylene) fitted with a rubber suction cap.
  • the tube is dipped into the subject fluid and the rubber cap is squeezed to fill the suction pipe with a suitable quantity (about 0.3 ml) of the test fluid to obtain a filtrate.
  • the tube is disconnected and the filtrate is directly used for the pregnancy diagnostic test. For instance, two drops of the above filtrate are dripped on a clean glass plate for LDAR or LAIR, or a HAIR test is carried out with 0.1 ml in a test tube.
  • the present invention further provides a kit for the pretreatment of the subject fluids, which comprises a tube packed with about 20 to 100 mg of the carboxylic acid-type cation exchange resin fiber or a siliconized glass fiber, and a pipe fitted with a rubber suction cap, to which said tube is to be connected at its lower end.
  • the pretreatment according to this invention removes the interfering components and turbidity elements without causing any substantial loss of HCG in the subject fluid, thus leading to remarkable improvements in sensitivity and reliability of the pregnancy test, especially LDAR.
  • carboxylic acid-type cation exchange resin fiber and siliconized glass fiber used in these tests and examples are as follows:
  • the carboxylic acid-type cation exchange resin fiber was prepared by the procedure described in Example 1 of Japanese Patent Application Laid-Open No. 14389/1974. It has a triazine-or tetrazine-cross linked structure and a cation exchange capacity of 6.4 meq/g, and is a pale-pinkish in appearance. In the infrared region of the spectrum this fiber showed a strong carbonyl band at 1600-1700 cm -1 but showed no nitrile absorption (2250 cm -1 ). This resin fiber was used in the form of filament with 6 denier except Example 4 wherein it was used in the form of staple fiber of 1 mm inn length with 3 denier.
  • the siliconized glass fiber was prepared as follows. A glass fiber with a diameter of about 10 ⁇ m was dewaxed with acetone and diethyl ether, immersed in a 1% solution of dimethylpolysiloxane in trichloroethylene for one minute, heat-treated at 200° C. for one hour and finally washed with 20% ethanol.
  • the filters of this invention effectively remove the components which would interfere with the reactions. Thus, they reduce considerably the incidence of misdiagnosing nonpregnancy as pregnancy.
  • HCG was added to 3 urine samples from healthy nonpregnant women to give an HCG concentration of one I.U./ml, and each sample was filtered as described hereinbefore. The residual HCG (%) in each filtered urine sample was measured by radioimmunoassay.
  • cellulosic filter paper absorbent cotton, wool, untreated glass fiber, viscose rayon, nylon, polyester, polypropylene, polyvinyl chloride, polyurethane and carboxymethylcellulose showed up to 65% adsorption of HCG. Substantially no adsorption of HCG occurred with carboxylic acid-type cation exchange resin fiber, siliconized glass fiber, cellulose acetate or polyacrylonitrile fiber.
  • Polyethylene tubes 5.0 mm in inside diameter, were respectively packed with 50 mg of carboxylic acid-type cation exchange resin fiber or siliconized glass fiber of the present invention, absorbent cotton, cellulose acetate fiber, polyacrylonitrile fiber and carboxymethylcellulose fiber and 400 urine samples from nonpregnant women were filtered with the above tubes by the procedure described hereinbefore, to obtain 0.3 ml of filtered urine from each urine sample. Two drops of each filtered urine sample were subjected to the LDAR tests.
  • Urine samples from 200 women definitely diagnosed as pregnant by clinical diagnoses were subjected to the LDAR test after filtration under the same conditions as in Example 1 using the carboxylic acid-type cation exchange resin fiber or siliconized glass fiber of the present invention or absorbent cotton, cellulose acetate fiber, polyacrylonitrile fiber or carboxymethylcellulose fiber.
  • Serum samples from 50 nonpregnant women and 50 pregnant women were filtered through the carboxylic acid-type cation exchange resin fiber or siliconized glass fiber used as a filter material under the same conditions as in Example 1 and two drops of each filtered serum sample were subjected to the LDAR test. All the serum samples from nonpregnant women reacted negatively, while all the serum samples from pregnant women showed positive reactions.
  • Urine samples from 50 nonpregnant women and 50 pregnant women were filtered through the carboxylic acid-type cation exchange resin staple fiber of 1 mm in length with 3 denier used as a filter material under the same conditions as in Example 1 and two drops of each filtered urine samples were subjected to the LDAR test. All the urine samples from nonpregnant women reacted negatively, while all the urine sample from pregnant women showed positive reactions.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Filtering Materials (AREA)

Abstract

By using a new pretreatment agent consisting essentially of a carboxylic acid-type cation exchange resin fiber or a siliconized glass fiber, the interfering components and the elements of turbidity present in a subject fluid for immunologic pregnancy test can be specifically removed without entailing a substantial loss of human chorionic gonadotropin contained in the subject fluid.

Description

The present invention relates to an improvement in the pretreatment of subject fluids for immunologic pregnancy tests.
Immunologic tests have been used for the diagnosis of pregnancy, which estimate the human chorionic gonadotropin (hereinafter briefly, HCG) in the urine or body fluid (serum, plasma, etc.) of a pregnant woman.
The principle of the anti-HCG antibody-sensitized latex agglutination test (latex direct agglutination reaction; hereinafter briefly, LDAR) is that as a latex particles carrying anti-HCG antibodies as adsorbed thereon are admixed with a subject urine, serum or plasma sample, the latex particles are agglutinated if HCG is present in the sample, the detection of such agglutination establishing a diagnosis of pregnancy. On the other hand, the principle of the HCG-sensitized latex agglutination inhibition test (latex agglutination inhibition reaction; hereinafter briefly, LAIR), is that as a latex carrying HCG as adsorbed thereon is admixed with a given amount of an anti-HCG antiserum, the latex particles are agglutinated, but if the latex is added after admixture of an HCG-containing subject fluid with a given amount of anti-HCG antiserum, the latex will not be agglutinated because the anti-HCG antibody has already been coupled to the HCG in the subject fluid. This, in LAIR the absence of latex agglutination establishes a diagnosis of pregnancy. Another method is the hemagglutination inhibition test (hereinafter briefly, HAIR) in which a diagnosis of pregnancy is performed using HCG-sensitized human or animal red blood cells in place of latex particles.
These immunologic pregnancy tests tend to give false results in early stages of pregnancy because the secretion of HCG in this period is so small that only a weak agglutination (or inhibition) reaction takes place. Moreover, sensitized latex and sensitized red blood cells may undergo non-specific reactions independently of the immunologic reaction of HCG with the anti-HCG antibody. Therefore, when the urine or serum containing a variety of components is assayed by the above methods, the agglutination (or inhibition) reaction is interfered with by components other than HCG in the sample to lead to a false diagnosis.
Subject fluids could also be turbid and if such fluids are directly assayed, false results may ensue. To prevent such false results, the fluids are usually filtered prior to the agglutination (inhibition) reaction.
The filter materials conventionally employed are cellulosic filter paper, absorbent cotton, cellulose acetate, polyacrylonitrile, carboxylmethylcellulose and other fiber but none of them is fully satisfactory. For instance, cellulosic filter paper and absorbent cotton are capable of removing the turbidity but have the disadvantage that HCG is also adsorbed. Cellulose acetate and polyacrylonitrile fiber are not efficient enough to thoroughly remove interferring components. While fibrous carboxylmethylcellulose is highly capable of removing the turbidity and interfering components, it entails adsorption of HCG.
With the above technical difficulties by way of background, the present inventors have unexpectedly found that the interfering components and the elements of turbidity present in the subject fluids can be specifically removed without entailing a substantial loss of HCG by contacting the subject fluids with a carboxylic acid-type cation exchange resin fiber or a siliconized glass fiber.
Thus, the principal object of the present invention is to provide an excellent agent for pretreating a subject fluid for pregnancy tests by means of an immunologic assay of HCG, which consists essentially of a carboxylic acid-type cation exchange resin fiber or a siliconized glass fiber. Another object is to provide an improved method for pretreating the subject fluids with use of said agent. Other objects will be made clear from the description and claims hereinafter.
The carboxylic acid-type cation exchange resin fiber used in this invention preferably has a cation exchange capacity of at least about 1.5 meq/g and, especially, about 5 to 8 meq/g. For example, a preferable fiber may be prepared by reacting a polymer molding containing at least 40 weight percent of acrylonitrile with hydrazine or a homolog of hydrazine to provide said polymer molding with an anion exchange capacity of 0.01 to 3.0 meq/g and, then, hydrolyzing the residual nitrile groups with alkali or mineral acid to introduce cation-exchanging groups into the molding (cf. Japanese Patent Application Laid-Open No. 14389/1974 (Tokukai Sho 49-14389)).
The siliconized glass fiber may be prepared by treating an ordinary glass fiber with a compound of silicon or a silicon-containing composition such as silane coupling agents (organofunctional silanes), silicone oil, silicone oil emulsion, silicone varnish, silicone varnish emulsion, etc. This siliconization treatment is generally carried out by impregnating a glass fiber with an aqueous or organic solvent solution of said compound of silicon or silicon-containing composition and heating the fiber (usually at about 100° to 300° C.).
The carboxylic acid-type cation exchange resin fiber and siliconized glass fiber may be used alone or in combination. The carboxylic acid-type cation exchange resin fiber is advantageously used in the form of filament or staple fiber (preferably 0.1 to 2 mm in length) with a denier number of about 2 to 15. The siliconized glass fiber is preferably used in the form of filament with a diameter of about 5 to 15 μm.
In contacting the subject fluid, such as the urine, serum or plasma of a woman, with the above-mentioned fiber, the fluid may be filtered through a layer of the fiber or, alternatively, the fluid may be admixed with the fiber and then separated (by filtration, centrifugal separation, etc.), although it is generally preferable to filter the subject fluid through the fibrous layer. A typical filtration procedure is as follows. A tube (preferably made from polyethylene) is packed with about 20 to 100 mg, most preferably about 50 mg, of said fiber and connected to the lower end of a pipe (preferably made from polyethylene) fitted with a rubber suction cap. Then, the tube is dipped into the subject fluid and the rubber cap is squeezed to fill the suction pipe with a suitable quantity (about 0.3 ml) of the test fluid to obtain a filtrate. The tube is disconnected and the filtrate is directly used for the pregnancy diagnostic test. For instance, two drops of the above filtrate are dripped on a clean glass plate for LDAR or LAIR, or a HAIR test is carried out with 0.1 ml in a test tube.
The present invention further provides a kit for the pretreatment of the subject fluids, which comprises a tube packed with about 20 to 100 mg of the carboxylic acid-type cation exchange resin fiber or a siliconized glass fiber, and a pipe fitted with a rubber suction cap, to which said tube is to be connected at its lower end.
The pretreatment according to this invention removes the interfering components and turbidity elements without causing any substantial loss of HCG in the subject fluid, thus leading to remarkable improvements in sensitivity and reliability of the pregnancy test, especially LDAR.
The beneficial results of this invention will be further explained by the following tests and working examples.
The carboxylic acid-type cation exchange resin fiber and siliconized glass fiber used in these tests and examples are as follows:
The carboxylic acid-type cation exchange resin fiber was prepared by the procedure described in Example 1 of Japanese Patent Application Laid-Open No. 14389/1974. It has a triazine-or tetrazine-cross linked structure and a cation exchange capacity of 6.4 meq/g, and is a pale-pinkish in appearance. In the infrared region of the spectrum this fiber showed a strong carbonyl band at 1600-1700 cm-1 but showed no nitrile absorption (2250 cm-1). This resin fiber was used in the form of filament with 6 denier except Example 4 wherein it was used in the form of staple fiber of 1 mm inn length with 3 denier.
The siliconized glass fiber was prepared as follows. A glass fiber with a diameter of about 10 μm was dewaxed with acetone and diethyl ether, immersed in a 1% solution of dimethylpolysiloxane in trichloroethylene for one minute, heat-treated at 200° C. for one hour and finally washed with 20% ethanol.
In the following tests and examples, LDAR and HAIR tests were respectively performed in conformity with the procedures described in the following literature:
LDAR test: J. Pharm. Soc. Japan, 98, 376(1978)
HAIR test: Acta Endocr. (Kbh), Suppl. 70(1962)
TEST EXAMPLE 1
Lower portions of polyethylene tubes with an inside diameter of 5 mm and a height of 45 mm were respectively packed with 50 mg of the above fibers according to this invention and the filtration procedure described hereinbefore was followed to obtain 0.3 ml of filtered urine or serum. As the cellulosic filter paper, Toyo Filter No. 50 (dia. 5.5 cm, wt. 237 mg) was used. The paper was pursed and placed over a funnel and 1.5 ml of urine or serum was passed.
As regards subject fluids, 10 urine specimens, with especially high degrees of interference, from those of nonpregnant women were selected. The five serum specimens from nonpregnant women were also employed. Each specimen was filtered as described hereinbefore and submitted to LDAR and HAIR tests. As controls, unfiltered samples were also tested. The results are presented in Table 1 and 2 appearing later.
The unfiltered urine specimens of nonpregnant women used in these tests showed overtly positive results in 5 out of 10 cases in LDAR, with the remaining 5 cases giving doubtful-positive results, i.e. intermediate between negative and positive reactions. In HAIR, one case was positive and 3 cases were doubtful positive. The influence of components leading to false results is particularly evident in LDAR but their incidence is reduced by filtration. The incidences of false results with various filter materials, when doubtful-positive results were added to positive results, were as follows. Cellulosic filter paper 5/10; absorbent cotton 5/10; wool 3/10; untreated glass fiber 3/10; viscose rayon 5/10; nylon 5/10; polyester 5/10; polypropylene 5/10; polyvinyl chloride 5/10; polyacrylonitrile 3/10; polyurethane 4/10; cellulose acetate 2/10; carboxymethylcellulose 1/10.
When the carboxylic acid-type cation exchange resin fiber or siliconized glass fiber was employed, all cases were found to be negative. In HAIR runs using filtered urine, all cases were found to be negative. The results of LDAR runs on nonpregnant sera, filtered through different filters, are shown in Table 3. Without filtration, the incidence of false results was 2/5 but with filtered sera all specimens were found to be negative, irrespective of the filter materials employed.
As mentioned above, when tests are carried out on unfiltered urine or serum, specimens which ought to be negative tend to give positive reactions, thus leading to misdiagnoses. Moreover, even with cellulosic filter paper, absorbent cotton, untreated glass, viscose rayon, nylon, polyester, polypropylene, polyvinyl chloride, polyacrylonitrile, polyurethane, cellulose acetate or carboxymethylcellulose fibers etc., specimens which ought to be negative sometimes produce positive results, thus leading again to misdiagnoses.
LDAR tests were performed on 10 urine samples from women in early stages of pregnancy which were lean in HCG. The results are shown in Table 4. When the urine samples were not filtered, all cases were found to be positive. However, when specimens were filtered through cellulosic filter paper or absorbent cotton, the reaction was considerably weakened so that pregnant women who ought to be positive were falsely found to be nonpregnant. With viscose rayon and carboxymethylcellulose, the incidence of false results was 2/10. The reaction was invariably weak when wool, untreated glass fiber, nylon, polyester, polypropylene, polyvinyl chloride and polyurethane were employed, the incidence of false results being 1/10 for each. In contrast, all cases were found to be positive with the carboxylic acid-type cation exchange resin and siliconized glass fibers according to this invention as well as with polyacrylonitrile and cellulose acetate.
It is necessary to filter subject fluids in order to remove turbidity and interfering components. However, depending on the kind of filter material, the HCG in the test fluid is adsorbed on the filter to cause a misdiagnosis.
When the carboxylic acid-type cation exchange resin or siliconized glass fiber is employed, substantially no HCG adsorption takes place. Moreover, the filters of this invention effectively remove the components which would interfere with the reactions. Thus, they reduce considerably the incidence of misdiagnosing nonpregnancy as pregnancy.
TEST EXAMPLE 2
HCG was added to 3 urine samples from healthy nonpregnant women to give an HCG concentration of one I.U./ml, and each sample was filtered as described hereinbefore. The residual HCG (%) in each filtered urine sample was measured by radioimmunoassay.
As shown in Table 5, cellulosic filter paper, absorbent cotton, wool, untreated glass fiber, viscose rayon, nylon, polyester, polypropylene, polyvinyl chloride, polyurethane and carboxymethylcellulose showed up to 65% adsorption of HCG. Substantially no adsorption of HCG occurred with carboxylic acid-type cation exchange resin fiber, siliconized glass fiber, cellulose acetate or polyacrylonitrile fiber.
EXAMPLE 1
Polyethylene tubes, 5.0 mm in inside diameter, were respectively packed with 50 mg of carboxylic acid-type cation exchange resin fiber or siliconized glass fiber of the present invention, absorbent cotton, cellulose acetate fiber, polyacrylonitrile fiber and carboxymethylcellulose fiber and 400 urine samples from nonpregnant women were filtered with the above tubes by the procedure described hereinbefore, to obtain 0.3 ml of filtered urine from each urine sample. Two drops of each filtered urine sample were subjected to the LDAR tests.
As shown in Table 6 appearing later, for the urine samples filtered through absorbent cotton, 10 out of 400 samples showed positive reactions and 35 doubtful-positive reactions; with cellulose acetate, 7 positive and 8 doubtful-positive; with polyacrylonitrile, 7 positive and 13 doubtful-positive. With carboxymethylcellulose, too, 1 showed positive reaction and 2 doubtful-positive reactions. On the contrary, with the carboxylic acid-type cation exchange resin fiber or siliconized glass fiber, all the samples (400 samples) gave negative results. In this manner those components which possibly interfere with the diagnostic reaction can be removed to a very great extent by the method of the present invention.
EXAMPLE 2
Urine samples from 200 women definitely diagnosed as pregnant by clinical diagnoses were subjected to the LDAR test after filtration under the same conditions as in Example 1 using the carboxylic acid-type cation exchange resin fiber or siliconized glass fiber of the present invention or absorbent cotton, cellulose acetate fiber, polyacrylonitrile fiber or carboxymethylcellulose fiber.
As shown in Table 7 appearing later, in the case of absorbent cotton, polyacrylonitrile and carboxymethylcellulose, 10, 3 and 3 cases, respectively, were erroneously diagnosed as nonpregnant. When the carboxylic acid-type cation exchange resin fiber was used as the filter material according to the invention, all the samples reacted positively in accord with the results of the definite clinical diagnosis. Also in the case where the siliconized glass fiber was used, all the cases showed positive results except for one case in which the reaction was doubtful-positive.
EXAMPLE 3
Serum samples from 50 nonpregnant women and 50 pregnant women were filtered through the carboxylic acid-type cation exchange resin fiber or siliconized glass fiber used as a filter material under the same conditions as in Example 1 and two drops of each filtered serum sample were subjected to the LDAR test. All the serum samples from nonpregnant women reacted negatively, while all the serum samples from pregnant women showed positive reactions.
EXAMPLE 4
Urine samples from 50 nonpregnant women and 50 pregnant women were filtered through the carboxylic acid-type cation exchange resin staple fiber of 1 mm in length with 3 denier used as a filter material under the same conditions as in Example 1 and two drops of each filtered urine samples were subjected to the LDAR test. All the urine samples from nonpregnant women reacted negatively, while all the urine sample from pregnant women showed positive reactions.
              TABLE 1                                                     
______________________________________                                    
Comparison of different pretreatments of                                  
urine samples from nonpregnant women (LDAR)                               
           Urine No.                                                      
Pretreatment 1     2     3   4   5   6   7   8   9   10                   
______________________________________                                    
Without filtration                                                        
             +     +     ±                                             
                             ±                                         
                                 +   ±                                 
                                         ±                             
                                             ±                         
                                                 +   +                    
Filtration through                                                        
Cellulosic filter paper                                                   
             -     +     -   ±                                         
                                 -   -   ±                             
                                             -   ±                     
                                                     +                    
Absorbent cotton                                                          
             -     +     -   ±                                         
                                 -   -   ±                             
                                             -   ±                     
                                                     +                    
Wool         -     +     -   -   -   -   -   -   ±                     
                                                     +                    
Untreated glass fiber                                                     
             -     +     -   -   -   -   -   -   ±                     
                                                     +                    
Viscose rayon                                                             
             -     +     -   ±                                         
                                 -   -   ±                             
                                             -   ±                     
                                                     +                    
Nylon        -     +     -   ±                                         
                                 -   -   ±                             
                                             -   ±                     
                                                     +                    
Polyester    -     +     -   ±                                         
                                 -   -   ±                             
                                             -   +   +                    
Polypropylene                                                             
             -     +     -   ±                                         
                                 -   -   ±                             
                                             -   +   +                    
Polyvinyl chloride                                                        
             -     ±  -   ±                                         
                                 -   -   ±                             
                                             -   +   +                    
Polyacrylonitrile                                                         
             -     ±  -   -   -   -   -   -   ±                     
                                                     +                    
Polyurethane -     +     -   -   -   -   ±                             
                                             -   ±                     
                                                     +                    
Cellulose acetate                                                         
             -     -     -   -   -   -   -   -   ±                     
                                                     +                    
Carboxymethyl-                                                            
cellulose    -     -     -   -   -   -   -   -   -   +                    
Carboxylic acid-type                                                      
cation exchange resin                                                     
fiber        -     -     -   -   -   -   -   -   -   -                    
Siliconized glass fiber                                                   
             -     -     -   -   -   -   -   -   -   -                    
______________________________________                                    
 Remarks:                                                                 
 + Positive results                                                       
 ± Doubtful-position results                                           
 - Negative results                                                       
 (The same shall apply hereinafter.)                                      

              TABLE 2                                                     
______________________________________                                    
Comparison of different pretreatments                                     
of urine samples from nonpregnant women                                   
(HAIR)                                                                    
           Urine No.                                                      
Pretreatment 1     2     3   4   5   6   7   8   9   10                   
______________________________________                                    
Without filtration                                                        
             -     ±  -   -   -   -   -   ±                         
                                                 ±                     
                                                     +                    
Filtration through                                                        
Cellulosic filter paper                                                   
             -     -     -   -   -   -   -   -   -   -                    
Absorbent cotton                                                          
             -     -     -   -   -   -   -   -   -   -                    
Wool         -     -     -   -   -   -   -   -   -   -                    
Untreated glass fiber                                                     
             -     -     -   -   -   -   -   -   -   -                    
Viscose rayon                                                             
             -     -     -   -   -   -   -   -   -   -                    
Nylon        -     -     -   -   -   -   -   -   -   -                    
Polyester    -     -     -   -   -   -   -   -   -   -                    
Polypropylene                                                             
             -     -     -   -   -   -   -   -   -   -                    
Polyvinyl chloride                                                        
             -     -     -   -   -   -   -   -   -   -                    
Polyacrylonitrile                                                         
             -     -     -   -   -   -   -   -   -   -                    
Polyurethane -     -     -   -   -   -   -   -   -   -                    
Cellulose acetate                                                         
             -     -     -   -   -   -   -   -   -   -                    
Carboxymethyl-                                                            
cellulose    -     -     -   -   -   -   -   -   -   -                    
Carboxylic acid-type                                                      
cation exchange resin                                                     
fiber        -     -     -   -   -   -   -   -   -   -                    
Siliconized glass fiber                                                   
             -     -     -   -   -   -   -   -   -   -                    
______________________________________                                    

              TABLE 3                                                     
______________________________________                                    
Comparison of different pretreatments of                                  
serum samples from nonpregnant women                                      
(LDAR)                                                                    
                  Serum No.                                               
Pretreatment        1     2     3   4   5                                 
______________________________________                                    
Without filtration  -     -     ±                                      
                                    -   +                                 
Filtration through                                                        
Cellulosic filter paper                                                   
                    -     -     -   -   -                                 
Absorbent cotton    -     -     -   -   -                                 
Wool                -     -     -   -   -                                 
Untreated glass fiber                                                     
                    -     -     -   -   -                                 
Viscose rayon       -     -     -   -   -                                 
Nylon               -     -     -   -   -                                 
Polyester           -     -     -   -   -                                 
Polypropylene       -     -     -   -   -                                 
Polyvinyl chloride  -     -     -   -   -                                 
Polyacrylonitrile   -     -     -   -   -                                 
Polyurethane        -     -     -   -   -                                 
Cellulose acetate   -     -     -   -   -                                 
Carboxymethylcellulose                                                    
                    -     -     -   -   -                                 
Carboxylic acid-type                                                      
cation exchange resin                                                     
fiber               -     -     -   -   -                                 
Siliconized glass fiber                                                   
                    -     -     -   -   -                                 
______________________________________                                    

              TABLE 4                                                     
______________________________________                                    
Comparison of different pretreatments of                                  
urine samples from women in early stages                                  
of pregnancy                                                              
           Urine No.                                                      
Pretreatment 1     2     3   4   5   6   7   8   9   10                   
______________________________________                                    
Without filtration                                                        
             +     +     +   +   +   +   +   +   +   +                    
Filtration through                                                        
Cellulosic filter paper                                                   
             +     -     +   +   ±                                     
                                     -   -   +   ±                     
                                                     -                    
Absorbent cotton                                                          
             +     -     +   +   ±                                     
                                     -   -   +   -   -                    
Wool         +     +     +   +   +   +   +   +   ±                     
                                                     -                    
Untreated glass fiber                                                     
             +     +     +   +   +   +   +   +   ±                     
                                                     -                    
Viscose rayon                                                             
             +     ±  +   +   ±                                     
                                     -   ±                             
                                             +   ±                     
                                                     -                    
Nylon        +     +     +   +   +   +   +   +   ±                     
                                                     -                    
Polyester    +     +     +   +   +   +   +   +   ±                     
                                                     -                    
Polypropylene                                                             
             +     +     +   +   +   +   +   +   ±                     
                                                     -                    
Polyvinyl chloride                                                        
             +     +     +   +   +   +   +   +   ±                     
                                                     -                    
Polyacrylonitrile                                                         
             +     +     +   +   +   +   +   +   +   ±                 
Polyurethane +     +     +   +   +   +   +   +   ±                     
                                                     -                    
Cellulose acetate                                                         
             +     +     +   +   +   +   +   +   +   +                    
Carboxymethyl-                                                            
cellulose    +     +     +   +   +   -   +   +   ±                     
                                                     -                    
Carboxylic acid-type                                                      
cation exchange resin                                                     
fiber        +     +     +   +   +   +   +   +   +   +                    
Siliconized glass fiber                                                   
             +     +     +   +   +   +   +   +   +   +                    
______________________________________                                    

              TABLE 5                                                     
______________________________________                                    
Residual HCG (%) in filtered urine samples                                
                   Urine No.                                              
Pretreatment         1      2      3                                      
______________________________________                                    
Filtration through                                                        
Cellulosic filter paper                                                   
                     47     45     50                                     
Absorbent cotton     41     35     40                                     
Wool                 62     65     59                                     
Untreated glass fiber                                                     
                     55     60     60                                     
Viscose rayon        40     40     35                                     
Nylon                92     85     88                                     
Polyester            79     80     80                                     
Polypropylene        85     80     75                                     
Polyvinyl chloride   90     88     88                                     
Polyacrylonitrile    100    95     97                                     
Polyurethane         95     86     90                                     
Cellulose acetate    100    99     98                                     
Carboxymethylcellulose                                                    
                     56     60     65                                     
Carboxylic acid-type                                                      
cation exchange resin                                                     
                     100    101    100                                    
fiber                                                                     
Siliconized glass fiber                                                   
                     100    96     99                                     
______________________________________                                    

              TABLE 6                                                     
______________________________________                                    
Comparison of different pretreatments                                     
of urine samples from 400 nonpregnant women                               
            Diagnosis (Number of cases)                                   
                        Doubtful-                                         
Pretreatment  Positive  positive   Negative                               
______________________________________                                    
Filtration through                                                        
Absorbent cotton                                                          
              10        35         355                                    
Cellulose acetate                                                         
              7         8          385                                    
Polyacrylonitrile                                                         
              7         13         380                                    
Carboxymethyl-                                                            
cellulose     1         2          397                                    
Carboxylic acid-type                                                      
cation exchange                                                           
resin fiber   0         0          400                                    
Siliconized glass                                                         
fiber         0         0          400                                    
______________________________________                                    

              TABLE 7                                                     
______________________________________                                    
Comparison of different pretreatments of                                  
urine samples from 200 pregnant women                                     
            Diagnosis (Number of cases)                                   
                        Doubtful-                                         
Pretreatment  Positive  positive   Negative                               
______________________________________                                    
Filtration through                                                        
Absorbent cotton                                                          
              181       9          10                                     
Cellulose acetate                                                         
              195       2          3                                      
Polyacrylonitrile                                                         
              193       4          3                                      
Carboxymethyl-                                                            
cellulose     189       6          5                                      
Carboxylic acid-                                                          
type cation                                                               
exchange resin                                                            
fiber         200       0          0                                      
Siliconized glass                                                         
fiber         199       1          0                                      
______________________________________

Claims (6)

What is claimed is:
1. A method for pretreating a subject fluid for a pregnancy test by means of an immunologic assay of human chorionic gonadotropin, which comprises removing the interfering components and turbidity from the subject fluid by contacting the subject fluid with a carboxylic acid-type cation exchange resin fiber having a cation exchange capacity of about 5 to 8 meq/g or a siliconized glass fiber prepared by impregnating a glass fiber with a solution of dimethylpolysiloxane and heating the fiber.
2. A method according to claim 1, wherein the subject fluid is woman's urine or serum.
3. A method according to claim 1, wherein the subject fluid is filtered through a layer of the carboxylic acid-type cation exchange resin fiber or the siliconized glass fiber.
4. A method according to claim 3, wherein the resin fiber is in the form of filament or staple fiber with a denier number of about 2 to 15.
5. A method according to claim 3, wherein the layer is of the siliconized glass fiber in the form of filament with a diameter of about 5 to 15 μm.
6. A method according to claim 3, wherein the amount of the fibrous layer is about 20 to 100 mg per 0.3 ml of the subject fluid.
US06/107,179 1978-12-25 1979-12-26 Pretreatment agent for subject fluid in pregnancy test Expired - Lifetime US4270923A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP53-160762 1978-12-25
JP53160762A JPS5933228B2 (en) 1978-12-25 1978-12-25 Pretreatment method and pretreatment agent for test solution for pregnancy diagnosis reaction

Publications (1)

Publication Number Publication Date
US4270923A true US4270923A (en) 1981-06-02

Family

ID=15721906

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/107,179 Expired - Lifetime US4270923A (en) 1978-12-25 1979-12-26 Pretreatment agent for subject fluid in pregnancy test

Country Status (8)

Country Link
US (1) US4270923A (en)
JP (1) JPS5933228B2 (en)
CA (1) CA1136972A (en)
DE (1) DE2951672A1 (en)
FR (1) FR2445528A1 (en)
GB (1) GB2040045B (en)
HK (1) HK9586A (en)
MY (1) MY8500422A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536478A (en) * 1984-04-05 1985-08-20 Seragan Diagnostics, Inc. Method for reducing non-specific interferences in agglutination immunoassays
US4600698A (en) * 1983-01-31 1986-07-15 Hoechst Aktiengesellschaft Immunological latex agglutination in presence of certain lactones or lactams
US5202267A (en) * 1988-04-04 1993-04-13 Hygeia Sciences, Inc. Sol capture immunoassay kit and procedure
US20030022390A1 (en) * 2002-05-30 2003-01-30 Stephens James Matthew Method and kit for making interfering substances in urine undetectable
US6867002B2 (en) * 1998-10-20 2005-03-15 Matsushita Electric Industrial Co., Ltd. Sample treating kit and sample treating method using the same for analysis with a biosensor
US7045098B2 (en) 2001-02-02 2006-05-16 James Matthew Stephens Apparatus and method for removing interfering substances from a urine sample using a chemical oxidant
EP1712917A1 (en) * 2003-12-24 2006-10-18 DENKA SEIKEN Co., Ltd. Simple membrane assay method and kit
EP1867991A1 (en) * 2005-07-25 2007-12-19 Arkray, Inc. Immunoassay method and immunoassay kit to be used therein
US20150174509A1 (en) * 2013-12-20 2015-06-25 Hollingsworth & Vose Company Filter media with fine staple fibers
US20150360156A1 (en) * 2013-12-20 2015-12-17 Hollingsworth & Vose Company Filter media and elements with fine staple fibers

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1146852A (en) * 1979-01-31 1983-05-24 Koichi Kondo Reagent for latex agglutination
EP0288311A1 (en) * 1987-04-24 1988-10-26 Pall Corporation Method of treating urine
ES2168402T3 (en) * 1996-03-18 2002-06-16 Stiftung Fur Diagnostische For IMMUNOANALYSIS IN PARTICLES WITH A COMPACT MATRIX.

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3171783A (en) * 1962-08-15 1965-03-02 Hyland Lab Diagnostic procedure
US3215500A (en) * 1961-06-12 1965-11-02 Donald L Bittner Laboratory mixer-separator
US3594993A (en) * 1966-11-14 1971-07-27 Dexter Corp Porous, bonded and impregnated, nonwoven filter sheet structure
US3873682A (en) * 1971-02-23 1975-03-25 Mochida Pharm Co Ltd Filter for urine samples to be used in pregnancy tests and method of using same
US3901657A (en) * 1974-04-29 1975-08-26 Sun Scient Inc Device for testing solutions and body fluids
US4138214A (en) * 1977-12-19 1979-02-06 American Home Products Corporation Diagnostic test utilizing human chorionic gonadotropin
US4160644A (en) * 1977-06-13 1979-07-10 Streck Laboratories, Inc. Platelet reference control and method of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3446598A (en) * 1966-12-22 1969-05-27 Miles Lab Chorionic gonadotropin separation process
CA1054515A (en) * 1975-12-17 1979-05-15 Morris L. Givner Ultrafiltration in pregnancy diagnosis

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3215500A (en) * 1961-06-12 1965-11-02 Donald L Bittner Laboratory mixer-separator
US3171783A (en) * 1962-08-15 1965-03-02 Hyland Lab Diagnostic procedure
US3594993A (en) * 1966-11-14 1971-07-27 Dexter Corp Porous, bonded and impregnated, nonwoven filter sheet structure
US3873682A (en) * 1971-02-23 1975-03-25 Mochida Pharm Co Ltd Filter for urine samples to be used in pregnancy tests and method of using same
US3901657A (en) * 1974-04-29 1975-08-26 Sun Scient Inc Device for testing solutions and body fluids
US4160644A (en) * 1977-06-13 1979-07-10 Streck Laboratories, Inc. Platelet reference control and method of preparation
US4138214A (en) * 1977-12-19 1979-02-06 American Home Products Corporation Diagnostic test utilizing human chorionic gonadotropin

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600698A (en) * 1983-01-31 1986-07-15 Hoechst Aktiengesellschaft Immunological latex agglutination in presence of certain lactones or lactams
US4536478A (en) * 1984-04-05 1985-08-20 Seragan Diagnostics, Inc. Method for reducing non-specific interferences in agglutination immunoassays
US5202267A (en) * 1988-04-04 1993-04-13 Hygeia Sciences, Inc. Sol capture immunoassay kit and procedure
US6867002B2 (en) * 1998-10-20 2005-03-15 Matsushita Electric Industrial Co., Ltd. Sample treating kit and sample treating method using the same for analysis with a biosensor
US7045098B2 (en) 2001-02-02 2006-05-16 James Matthew Stephens Apparatus and method for removing interfering substances from a urine sample using a chemical oxidant
US20030022390A1 (en) * 2002-05-30 2003-01-30 Stephens James Matthew Method and kit for making interfering substances in urine undetectable
US20070202611A1 (en) * 2003-12-24 2007-08-30 Denka Seiken Co., Ltd. Simple membrane assay method and kit
EP1712917A4 (en) * 2003-12-24 2007-08-01 Denka Seiken Kk Simple membrane assay method and kit
EP1712917A1 (en) * 2003-12-24 2006-10-18 DENKA SEIKEN Co., Ltd. Simple membrane assay method and kit
US7579195B2 (en) 2003-12-24 2009-08-25 Denka Seiken Co., Ltd Simple membrane assay method and kit
US20090286226A1 (en) * 2003-12-24 2009-11-19 Denka Seiken Co., Ltd. Simple membrane assay method and kit
EP2270508A1 (en) * 2003-12-24 2011-01-05 DENKA SEIKEN Co., Ltd. Membrane assay method and kit
US8404479B2 (en) 2003-12-24 2013-03-26 Denka Seiken Co., Ltd Simple membrane assay method and kit
EP1867991A1 (en) * 2005-07-25 2007-12-19 Arkray, Inc. Immunoassay method and immunoassay kit to be used therein
EP1867991A4 (en) * 2005-07-25 2008-06-04 Arkray Inc Immunoassay method and immunoassay kit to be used therein
US20150174509A1 (en) * 2013-12-20 2015-06-25 Hollingsworth & Vose Company Filter media with fine staple fibers
US20150360156A1 (en) * 2013-12-20 2015-12-17 Hollingsworth & Vose Company Filter media and elements with fine staple fibers

Also Published As

Publication number Publication date
FR2445528B1 (en) 1985-01-11
GB2040045B (en) 1983-05-11
DE2951672A1 (en) 1980-07-03
DE2951672C2 (en) 1987-10-08
CA1136972A (en) 1982-12-07
GB2040045A (en) 1980-08-20
MY8500422A (en) 1985-12-31
JPS5587048A (en) 1980-07-01
JPS5933228B2 (en) 1984-08-14
FR2445528A1 (en) 1980-07-25
HK9586A (en) 1986-02-14

Similar Documents

Publication Publication Date Title
US4270923A (en) Pretreatment agent for subject fluid in pregnancy test
Heidelberger et al. QUANTITATIVE STUDIES ON ANTIBODY PURIFICATION: I. The Dissociation of Precipitates Formed by Pneumococcus Specific Polysaccharides and Homologous Antibodies
US6057166A (en) Fecal test method
US3873682A (en) Filter for urine samples to be used in pregnancy tests and method of using same
DE3882058T2 (en) Immunoreactive reagent, process for its preparation and its use in the determination of an immunoreactive species.
DE2851150C2 (en) Method for the immunological examination of a serum sample
US3641235A (en) Immunological reagent and process for making same
US5169757A (en) Antibodies or antigens bound to a macroporous hydrophobic synthetic polymer cloth for immunological techniques
DE2450523B2 (en) PROCEDURE FOR THE IMMUNOLOGICAL DETECTION OF PROTEINS
EP0001223A2 (en) Latex coated with a polyhydroxy compound, process for the preparation of this latex, immunological reagent containing this latex, process for the preparation of this reagent, application of this reagent, testing procedure utilising this reagent and reagent kit containing this reagent
JPH0785083B2 (en) Device for separating plasma from whole blood and its use
DE68917039T2 (en) Microporous article with stabilized specific binding reagent, procedure for use and a diagnostic test kit.
DE69934697T2 (en) METHOD FOR DETECTING LEGIONELLA BACTERIA USING PURIFIED ANTIGEN-SPECIFIC ANTIBODY
CN109799355A (en) First function five fluorescent microsphere joint-detection device and preparation method thereof
EP0537827A1 (en) Method, test device and kit for assay of specific binding ligand using controlled flow through filtration membrane
DE3717402A1 (en) METHOD FOR DETERMINING PROTEINS AND MEANS THEREFOR
WO1997023781A1 (en) Fecal test method and device
DE3303083A1 (en) IMMUNOLOGICAL LATEX AGGLUTINATION METHOD AND AGENT
US2314336A (en) Method and means for simultaneously testing and filtering solutions
JPS6472065A (en) Method and apparatus for removing blood cell from body liquor containing red blood cell
EP0753149A1 (en) Detection of analytes
USRE29474E (en) Method for the determination of proteins and polypeptides
Wiener et al. Quantitative Studies on the Group-Specific Substances in Human Blood and Saliva: II. Group-Specific Substance A, with Special Reference to the Subgroups
DE3780280T2 (en) ENZYME IMMUNOTEST.
AU693181B2 (en) Methods and apparatus for detecting analytes in body fluid utilizing specific binding agents and incorporating wiping action

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE